Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Abstract:
G protein-coupled receptor hetero-oligomerization is emergingas an important regulator of ligand-dependent transmembranesignaling, but precisely how receptor heteromers affect receptorpharmacology remains largely unknown. In this study, we haveattempted to identify the functional significance of the heteromericcomplex between CXCR4 and CXCR7 chemokine receptors. We demonstratethat co-expression of CXCR7 with CXCR4 results in constitutiverecruitment of β-arrestin to the CXCR4·CXCR7 complexand simultaneous impairment of Gi-mediated signaling. CXCR7/CXCR4co-expression also results in potentiation of CXCL12 (SDF-1)-mediateddownstream β-arrestin-dependent cell signaling pathways,including ERK1/2, p38 MAPK, and SAPK as judged from the resultsof experiments using siRNA knockdown to deplete β-arrestin.Interestingly, CXCR7/CXCR4 co-expression enhances cell migrationin response to CXCL12 stimulation. Again, inhibition of β-arrestinusing either siRNA knockdown or a dominant negative mutant abrogatesthe enhanced CXCL12-dependent migration of CXCR4/CXCR7-expressingcells. These results show how CXCR7, which cannot signal directlythrough G protein-linked pathways, can nevertheless affect cellularsignaling networks by forming a heteromeric complex with CXCR4.The CXCR4·CXCR7 heterodimer complex recruits β-arrestin,resulting in preferential activation of β-arrestin-linkedsignaling pathways over canonical G protein pathways. CXCL12-dependentsignaling of CXCR4 and its role in cellular physiology, includingcancer metastasis, should be evaluated in the context of potentialfunctional hetero-oligomerization with CXCR7.
2 To whom correspondence may be addressed: Laboratory of Molecular Biology and Biochemistry, Rockefeller University, 1230 York Ave., New York, NY 10065. Tel.: 212-327-8284; Fax: 212-327-7904; E-mail: sakmar{at}rockefeller.edu.
3 To whom correspondence may be addressed: Eisai, Inc., 300 Tice Blvd., Woodcliff Lake, NJ 07677. E-mail: Pallavi_Sachdev{at}eisai.com.
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Elizabeth M. Adler (20 September 2011) Sci. Signal.4 (191), ec259.
[DOI: 10.1126/scisignal.4191ec259] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
International Union of Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors.
A. Klos, E. Wende, K. J. Wareham, and P. N. Monk (2013)
Pharmacol. Rev.
65, 500-543
|Abstract »|Full Text »|PDF »